Plasmodium falciparum: development of a transgenic line for screening antimalarials using firefly luciferase as the reporter.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Experimental parasitology

• Publication date

  2008-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.exppara.2008.05.003PMID 18579134PMCID PMC2559859
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Stage independent chloroquine resistance and chloroquine toxicity revealed via spinning disk confocal microscopy.

  2008cited by this paper
• Bioluminescent Assays for High-Throughput Screening

  2007cited by this paper
• Assessment and Continued Validation of the Malaria SYBR Green I-Based Fluorescence Assay for Use in Malaria Drug Screening

  2007cited by this paper
• Advances and perspectives in Leishmania cell based drug-screening procedures.

  2007cited by this paper
• Validation of a Plasmodium falciparum parasite transformed with green fluorescent protein for antimalarial drug screening.

  2007cited by this paper
• Multiple Antibiotics Exert Delayed Effects against the Plasmodium falciparum Apicoplast

  2007cited by this paper
• Comparison of a SYBR Green I-Based Assay with a Histidine-Rich Protein II Enzyme-Linked Immunosorbent Assay for In Vitro Antimalarial Drug Efficacy Testing and Application to Clinical Isolates

  2007cited by this paper
• Malaria Parasites Can Develop Stable Resistance to Artemisinin but Lack Mutations in Candidate Genes atp6 (Encoding the Sarcoplasmic and Endoplasmic Reticulum Ca2+ ATPase), tctp, mdr1, and cg10

  2006cited by this paper
• In Vitro Antimalarial Activity of Azithromycin, Artesunate, and Quinine in Combination and Correlation with Clinical Outcome

  2006cited by this paper
• High-Throughput Plasmodium falciparum Growth Assay for Malaria Drug Discovery

  2006cited by this paper
• Cytotoxic Effect of Curcumin on Malaria Parasite Plasmodium falciparum: Inhibition of Histone Acetylation and Generation of Reactive Oxygen Species

  2006cited by this paper
• 3' gene regulatory elements required for expression of the Plasmodiumfalciparum developmental protein, Pfs25.

  2006cited by this paper
• Strict Pairing of var Promoters and Introns Is Required for var Gene Silencing in the Malaria Parasite Plasmodium falciparum*

  2006cited by this paper
• Real-time in vivo imaging of transgenic bioluminescent blood stages of rodent malaria parasites in mice

  2006cited by this paper
• Use of New T-Cell-Based Cell Lines Expressing Two Luciferase Reporters for Accurately Evaluating Susceptibility to Anti-Human Immunodeficiency Virus Type 1 Drugs

  2006cited by this paper
• Tetracyclines Specifically Target the Apicoplast of the Malaria Parasite Plasmodium falciparum

  2006cited by this paper
• Artemisinin-based combinations

  2005cited by this paper
• Manipulating the Plasmodium genome.

  2005cited by this paper
• The global distribution of clinical episodes of Plasmodium falciparum malaria

  2005influential reference
• Drug sensitivity of Plasmodium falciparum along the Thai–Myanmar border using the new field-deployable HRP2 in vitro assay

  2005cited by this paper
• Functional assays for screening GPCR targets.

  2005cited by this paper
• High-Throughput Assays Using a Luciferase-Expressing Replicon, Virus-Like Particles, and Full-Length Virus for West Nile Virus Drug Discovery

  2005cited by this paper
• Simple Histidine-Rich Protein 2 Double-Site Sandwich Enzyme-Linked Immunosorbent Assay for Use in Malaria Drug Sensitivity Testing

  2005cited by this paper
• Association of failures of seven-day courses of artesunate in a non-immune population in Bangui, Central African Republic with decreased sensitivity of Plasmodium falciparum.

  2005cited by this paper
• Field Evaluation of a Novel Colorimetric Method—Double-Site Enzyme-Linked Lactate Dehydrogenase Immunodetection Assay—To Determine Drug Susceptibilities of Plasmodium falciparum Clinical Isolates from Northwestern Thailand

  2004cited by this paper
• Identification of regulatory elements in the Plasmodium falciparum genome.

  2004cited by this paper
• A novel DNA-based microfluorimetric method to evaluate antimalarial drug activity.

  2004cited by this paper
• A histidine-rich protein 2-based malaria drug sensitivity assay for field use.

  2004cited by this paper
• Novel, Rapid, and Inexpensive Cell-Based Quantification of Antimalarial Drug Efficacy

  2004cited by this paper
• Simple and Inexpensive Fluorescence-Based Technique for High-Throughput Antimalarial Drug Screening

  2004cited by this paper
• Bioluminescence and chemiluminescence in drug screening

  2003cited by this paper
• Targeting GFP to the malarial mitochondrion.

  2003cited by this paper
• Malaria transfection and transfection vectors.

  2003cited by this paper
• Histidine-Rich Protein II: a Novel Approach to Malaria Drug Sensitivity Testing

  2002cited by this paper
• Transfection technology and the study of drug resistance in the malaria parasite Plasmodium falciparum.

  2002cited by this paper
• Plasmodium falciparum: differential display analysis of gene expression during gametocytogenesis.

  2001cited by this paper
• Apparent drug failure following artesunate treatment of Plasmodium falciparum malaria in Freetown, Sierra Leone: four case reports.

  2001cited by this paper
• A colorimetric in vitro drug sensitivity assay for Plasmodium falciparum based on a highly sensitive double-site lactate dehydrogenase antigen-capture enzyme-linked immunosorbent assay.

  2001cited by this paper
• Luciferase, When Fused to an N-terminal Signal Peptide, Is Secreted from Transfected Plasmodium falciparum and Transported to the Cytosol of Infected Erythrocytes*

  2001cited by this paper
• Puromycin-N-acetyltransferase as a selectable marker for use in Plasmodium falciparum.

  2001cited by this paper
• Transformation of malaria parasites by the spontaneous uptake and expression of DNA from human erythrocytes.

  2001influential reference
• An alteration in concatameric structure is associated with efficient segregation of plasmids in transfected Plasmodium falciparum parasites.

  2001cited by this paper
• Luminescent proteins from Aequorea victoria: applications in drug discovery and in high throughput analysis

  2001cited by this paper
• Antibiotics for prophylaxis of Plasmodium falciparum infections: in vitro activity of doxycycline against Senegalese isolates.

  2000cited by this paper
• Stable Expression of a New Chimeric Fluorescent Reporter in the Human Malaria Parasite Plasmodium falciparum

  2000cited by this paper
• Antimalarial drug resistance and combination chemotherapy.

  1999cited by this paper
• A set of independent selectable markers for transfection of the human malaria parasite Plasmodium falciparum.

  1999cited by this paper
• A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays

  1999cited by this paper
• Two patients with falciparum malaria and poor in vivo responses to artesunate.

  1998cited by this paper
• Transformation with human dihydrofolate reductase renders malaria parasites insensitive to WR99210 but does not affect the intrinsic activity of proguanil.

  1997cited by this paper
• Simple, fast, and accurate fluorometric method to determine drug susceptibility of Plasmodium falciparum in 24-well suspension cultures

  1996cited by this paper
• Transfection of Plasmodium falciparum within human red blood cells.

  1995influential reference
• Use of radioactive ethanolamine incorporation into phospholipids to assess in vitro antimalarial activity by the semiautomated microdilution technique

  1992influential reference
• Induction and isolation of artemisinine-resistant mutants of Plasmodium falciparum.

  1985cited by this paper
• Cloning of naturally occurring mixed infections of malaria parasites.

  1981cited by this paper
• Synchronization of Plasmodium falciparum erythrocytic stages in culture.

  1979cited by this paper
• Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique

  1979influential reference
• Human malaria parasites in continuous culture.

  1976influential reference

• Next Generation Chemiluminescent Probes for Antimalarial Drug Discovery

  2024cites this paper
• Reporter parasite lines: valuable tools for the study of Plasmodium biology.

  2024cites this paper
• An adaptable, fit-for-purpose screening approach with high-throughput capability to determine speed of action and stage specificity of anti-malarial compounds

  2024cites this paper
• A versatile Plasmodium falciparum reporter line expressing NanoLuc enables highly sensitive multi-stage drug assays

  2023cites this paper
• The landscape of nature-derived antimalarials-potential of marine natural products in countering the evolving Plasmodium

  2022cites this paper
• Drug Repurposing of Quisinostat to Discover Novel Plasmodium falciparum HDAC1 Inhibitors with Enhanced Triple-Stage Antimalarial Activity and Improved Safety.

  2022cites this paper
• Characterization of protein arginine methyltransferase I from Plasmodium falciparum

  2022cites this paper
• A novel multistage antiplasmodial inhibitor targeting Plasmodium falciparum histone deacetylase 1

  2020cites this paper
• Screening Marine Natural Products for New Drug Leads against Trypanosomatids and Malaria

  2020cites this paper
• Generation of Novel Plasmodium falciparum NF135 and NF54 Lines Expressing Fluorescent Reporter Proteins Under the Control of Strong and Constitutive Promoters

  2020cites this paper
• Synthesis, structure-activity relationship and antimalarial efficacy of 6-chloro-2-arylvinylquinolines.

  2020cites this paper
• Discovery of fast-acting dual-stage antimalarial agents by profiling pyridylvinylquinoline chemical space via copper catalyzed azide-alkyne cycloadditions.

  2020cites this paper
• A novel multistage antiplasmodial inhibitor targeting Plasmodium falciparum histone deacetylase 1

  2020cites this paper
• Assay methods for in vitro and in vivo anti-Babesia drug efficacy testing: Current progress, outlook, and challenges.

  2019cites this paper
• Development of NanoLuc-PEST expressing Leishmania mexicana as a new drug discovery tool for axenic- and intramacrophage-based assays

  2018cites this paper
• Screening Method for Anti-Colon Cancer Drugs Using Two Sensor Cell Lines with Human β4-Galactosyltransferase 4 Gene Promoters

  2018cites this paper
• Development in Assay Methods for in Vitro Antimalarial Drug Efficacy Testing: A Systematic Review

  2017influential citation
• Molecular genetic approaches to malaria research

  2017cites this paper
• Rapid Generation of Marker-Free P. falciparum Fluorescent Reporter Lines Using Modified CRISPR/Cas9 Constructs and Selection Protocol

  2016cites this paper
• An ultrasensitive NanoLuc-based luminescence system for monitoring Plasmodium berghei throughout its life cycle

  2016cites this paper
• Cell based assays for anti-Plasmodium activity evaluation.

  2016cites this paper
• Advances in Malaria Research

  2016cites this paper
• Enlightening the malaria parasite life cycle: bioluminescent Plasmodium in fundamental and applied research

  2015cites this paper
• Plasmodium falciparum Transfected with Ultra Bright NanoLuc Luciferase Offers High Sensitivity Detection for the Screening of Growth and Cellular Trafficking Inhibitors

  2014cites this paper
• CRIMALDDI: platform technologies and novel anti-malarial drug targets

  2013influential citation
• Plasmodium falciparum: generation of pure gametocyte culture by heparin treatment.

  2013cites this paper
• Amazonian Plant Natural Products: Perspectives for Discovery of New Antimalarial Drug Leads

  2013cites this paper
• Luminescent multiplex viability assay for Trypanosoma brucei gambiense

  2013cites this paper
• In vitro culture systems for the study of apicomplexan parasites in farm animals.

  2013cites this paper
• Evaluation of bioluminescence-based assays of anti-malarial drug activity

  2013cites this paper
• New approaches for the identification of drug targets in protozoan parasites.

  2013cites this paper
• Development of a Luciferase-Based Assay to Screen for Gametocyte-Specific Antimalarial Drugs

  2012cites this paper
• Validating a Firefly Luciferase-Based High-Throughput Screening Assay for Antimalarial Drug Discovery

  2012influential citation
• An improved single-step lysis protocol to measure luciferase bioluminescence in Plasmodium falciparum

  2012cites this paper
• Lack of Association of the S769N Mutation in Plasmodium falciparum SERCA (PfATP6) with Resistance to Artemisinins

  2012influential citation
• A transgenic Plasmodium falciparum NF54 strain that expresses GFP-luciferase throughout the parasite life cycle.

  2012cites this paper
• Exported proteins of the malaria parasite Plasmodium falciparum: characterization of blood-stage antigen 332

  2011cites this paper
• DEVELOPMENT OF A LUCIFERASE-BASED ASSAY TO SCREEN FOR GAMETOCYTE-SPECIFIC ANTIMALARIAL DRUGS by Becita

  2011influential citation
• Functional genetics in Apicomplexa: Potentials and limits

  2011cites this paper
• A toolbox to study liver stage malaria.

  2011cites this paper
• Discovery of Potent Small-Molecule Inhibitors of Multidrug-Resistant Plasmodium falciparum Using a Novel Miniaturized High-Throughput Luciferase-Based Assay

  2010cites this paper
• Characterization of PRMT1 from Plasmodium falciparum.

  2009cites this paper
• Current treatment and drug discovery against Leishmania spp. and Plasmodium spp.: a review.

  2009cites this paper
• An efficient fluorimetric method to measure the viability of intraerythrocytic Plasmodium falciparum

  2008cites this paper
• Bioluminescent Assays for High-Throughput Screening

  2007cites this paper